103672-2
Amoxicillin+Clavulanate [Susceptibility] for UTI
Active
Part Descriptions
LP15420-0 Amoxicillin+Clavulanate
The combination of Amoxicillin and clavulanate -- also known as Augmentin -- is an oral antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the -lactamase inhibitor, clavulanate . It is used in the treatment of otitis media, sinusitis, and infections caused by susceptible organisms involving the lower respiratory tract, skin and skin structure, and urinary tract; spectrum same as amoxicillin with additional coverage of beta-lactamase producing B. catarrhalis, H. influenzae, N. gonorrhoeae, and S. aureus (not MRSA). The expanded coverage of this combination makes it a useful alternative when penicillin resistance is present and patients cannot tolerate alternative treatments.
Source: Regenstrief Institute
LP234795-5 Isolate.UTI
Various agencies, including the FDA and CLSI in the U.S. and EUCAST in Europe, publish guidelines for determining susceptibility of different organisms to different antimicrobials. In most cases, susceptibility does not vary by infection site, but for a few specific types of infection, including meningitis, pneumonia and urinary tract infection, certain antimicrobials have different susceptibility thresholds, which are called "breakpoints". For terms in LOINC that represent specific breakpoints, the LOINC System will indicate the type of infection that the breakpoint is based on, for example, Isolate.meningitis, Isolate.pneumonia, and Isolate.UTI.
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Amoxicillin+Clavulanate:
Susc: Pt: Isolate.UTI: OrdQn: - Long Common Name
- Amoxicillin+Clavulanate [Susceptibility] for UTI
- Short Name
- Amoxicillin+Clav Susc Islt.UTI
- Display Name
- Amoxicillin+Clavulanate (Isolate.UTI) [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amoxicillin+Clavulanate
Part Model Get Info
- Component
- Amoxicillin+Clavulanate
LP15420-0
- Analyte
- Amoxicillin+Clavulanate
LP15420-0
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Susc
LP6870-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Isolate.UTI
LP234795-5
- System Core
- Isolate.UTI
LP234795-5
- Super System
- NULL
- Scale
- OrdQn
LP7752-1
- Method
- NULL
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.77
- Last Updated
- Version 2.77 (ADD)
- Order vs. Observation
- Both
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Amoxicilin+klavulanát: |
| de-DE | German (Germany) | Amoxicillin+Clavulanat: Synonyms: HWI |
| el-GR | Greek (Greece) | Αμοξικιλλίνη+Kλαβουλανικό: Synonyms: ABXBACT Kλαβουλανικό OrdQn Pt Susc Αμοξικιλλίνη Αμοξικιλλίνη+Kλαβουλανικό Απομονωμένο στέλεχος Απομονωμένο στέλεχος.λοίμωξη του ουροποιητικού |
| es-ES | Spanish (Spain) | Amoxicilina+Clavulánico: |
| fr-FR | French (France) | Amoxicilline+clavulanate: |
| it-IT | Italian (Italy) | Amoxicillina+Acido clavulanico: Synonyms: Isolato.Infezioni delle vie urinarie Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
| pl-PL | Polish (Poland) | Amoksycylina+klawulanian: Synonyms: Amoksycylina i kwas klawulanowy wrażliwość (mikroorganizmów) |
| zh-CN | Chinese (China) | 羟氨苄青霉素+棒酸: Synonyms: β-内酰胺酶抑制剂; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://